Full-year 2025 preliminary1 U.S. net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) total injection demand grew 17% year-over-year; regulatory submission for prefilled syringe ...
Investing.com -- InflaRx N.V. (NASDAQ:IFRX) stock dropped 2.5% Thursday after the biopharmaceutical company announced a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback